Pharmaceuticals in Brazil industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2018-23, and forecast to 2028). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Key Highlights
The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare. Market values refer to the value generated by market players.
The Brazilian pharmaceuticals registered revenues of $30.7 billion in 2023, representing a compound annual growth rate (CAGR) of 1.5% between 2018 and 2023.
Brazil captured a share of 5.2% in the American pharmaceuticals market, in 2023.
Scope
Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the pharmaceuticals market in Brazil
Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in Brazil
Leading company profiles reveal details of key pharmaceuticals market players’ global operations and financial performance
Add weight to presentations and pitches by understanding the future growth prospects of the Brazil pharmaceuticals market with five year forecasts
Reasons to Buy
What was the size of the Brazil pharmaceuticals market by value in 2023?
What will be the size of the Brazil pharmaceuticals market in 2028?
What factors are affecting the strength of competition in the Brazil pharmaceuticals market?
How has the market performed over the last five years?
Who are the top competitors in Brazil's pharmaceuticals market?
1 Executive Summary
1.1. Market value
1.2. Market value forecast
1.3. Geography segmentation
1.4. Market rivalry
1.5. Competitive landscape
2 Market Overview
2.1. Market definition
2.2. Market analysis
3 Market Data
3.1. Market value
4 Market Segmentation
4.1. Geography segmentation
5 Market Outlook
5.1. Market value forecast
6 Five Forces Analysis
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 Competitive Landscape
7.1. Who are the leading players?
7.2. What are the strengths of the leading players?
7.3. What are the recent developments in the market?
8 Company Profiles
8.1. Ache Laboratorios Farmaceuticos SA
8.2. Hypera SA
8.3. EMS Sigma Pharma
8.4. Eurofarma Laboratorios SA
9 Macroeconomic Indicators
9.1. Country data
10 Appendix
10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine
List of Tables
Table 1: Brazil pharmaceuticals market value: $ billion, 2018-23
Table 2: Brazil pharmaceuticals market geography segmentation: $ billion, 2023
Table 3: Brazil pharmaceuticals market value forecast: $ billion, 2023-28